Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Seeks Public/Private Partners For Device Epidemiology Network

This article was originally published in The Gray Sheet

Executive Summary

FDA is forming a public/private epidemiology network focused on better understanding of medical device performance over a product's lifespan

You may also be interested in...

FDA To Issue Final Device Post-Market Surveillance Plan In February

The device center plans to publish the final version of its national device post-market surveillance strategy and select a third-party group to run its MDEpiNet public-private partnership by the end of February.

CDRH Seeks To Expand Public-Private Medical Device Epidemiology Network

FDA hopes the MDEpiNet post-market surveillance program will be fully functional by the end of the year. A May public meeting is planned to catalyze the effort.

Delving Into Device Data: FDA's Epidemiology Network Is Taking Shape

FDA's new device epidemiology network, aimed at improving device surveillance, should be fully up and running this fall.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts